[1] |
ZENG Lijie, WANG Liang, YANG Lei .
Clinical features and treatment efficacy analysis of central nervous system involvement in extranodal nasal-type natural killer/T-cell lymphoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 81-87.
|
[2] |
WU Lili, ZHU Yingli, ZHUO Xiaolu, HUANG Lina, YE Dong.
Comparison of clinical efficacy of icotinib and gefitinib in the treatment of EGFR⁃mutated advanced lung adenocarcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(6): 642-646.
|
[3] |
LUO Xixi, CHEN Jiamei, SHI Wei, CHEN Yongshun.
Efficacy and safety of Regorafenib combined with PD⁃1 inhibitors in advanced microsatellite stable colorectal carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(5): 521-528.
|
[4] |
CHEN Xiaolei, ZHANG Yong, ZHANG Yue, LI Jie, ZHOU Hebing .
Retrospective analysis of efficacy and prognosis of newly diagnosed multiple myeloma patients with 1q21 amplification
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(5): 541-547.
|
[5] |
LIU Song, YU Guangji, WANG Qingdong.
Efficacy and prognostic factors of CalliSpheres drug⁃eluting bead transarterial chemoembolization on unresectable colorectal cancer liver metastases with systemic chemotherapy failure
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(2): 171-176.
|
[6] |
WANG Zimeng, XIANG Zuolin.
Clinical efficacy of stereotactic body radiation therapy on liver metastases
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(6): 641-646.
|
[7] |
YANG Guangzhong, GENG Chuanying, WU Yin, LIU Aijun, LENG Yun, LI Yanchen, GAO Wen, CHEN Wenming.
Clinical efficacy of domestic bortezomib (Xintai) in the treatment of multiple myeloma and its safety
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(4): 385-388.
|
[8] |
LIU Bin, YANG Fang, LIN Xiang, YUAN Zhenchao.
Clinical efficacy of local microwave ablation combined with percutaneous kyphoplasty in the treatment of advanced acetabular metastases
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(3): 301-304.
|
[9] |
TANG Zhihong, YUAN Du, CHEN Zhiwei, MENG Weida, WU Feixiang, WANG Xiaobo.
Value of the aspartate aminotransferase to lymphocyte ratio in evaluating prognosis of primary liver cancer with portal vein tumor thrombus patients before TACE
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(5): 572-577.
|
[10] |
WEI Lingchun, LIAO Xiaoli, HUANG Wenfeng, LIAO Sina, LIU Zhihui, LI Yongqiang.
Association between HJURP gene polymorphism and the efficacy and adverse reactions of oxaliplatin-based chemotherapy for advanced hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(4): 447-452.
|
[11] |
ZHAO Xiaojia, SU Weipeng, LI Xiaohong, QIN Yongde.
Implication of the SUVmax of 18F-FDG PET/CT images in predicting the therapeutic effects of non-Hodgkin's lymphoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(2): 227-231.
|
[12] |
CHEN Yanrong, WEI Cuiling, ZHANG Liyuan, QIN Ting.
Correlation of psychological distress with self-care efficacy in patients with gastrointestinal tumors
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(5): 426-430.
|
[13] |
HAN Zhongcheng, MA Lili, CUI Zhiwen, FENG Yanyan, WANG Fang.
Efficacy of first-line SOX chemotherapy plus Apatinib for advanced gastric cancer patients
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(1): 62-67.
|
[14] |
Wang Shuaibing,Guo Qian,Wu Zhenming,Liu Jun,Qi Xiuheng.
Clinical efficacy of capecitabine combined with Endostar in the treatment of advanced colon cancer after stent implantation
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(5): 360-364.
|
[15] |
Wu Linghong,Huang Tianren,Deng Wei,Huang Zhibi,Guo Jiao,Huang Yueying.
Meta-analysis:the relationship of hepatitis B virus genotypes,subgenotypes and hepato-cellular carcinoma in China
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(5): 365-370.
|